SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1984 |
| Sector | Medical Products |
| Employees | 1,500 |
| Revenue | 354M USD (2023) |
Artivion is a manufacturer, processor, and distributor of implantable living tissues and medical devices used in cardiac and vascular surgical procedures. Artivion was incorporated in 1984 and is based in Kennesaw, Georgia.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 8 |
| Sector (Medical Products) | 6 of 8 |
| Type (Add-on Acquisition) | 4 of 6 |
| Country (Germany) | 1 of 1 |
| Year (2017) | 1 of 1 |
| Size (of disclosed) | 1 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-03-18 |
ProCol Vascular Bioprosthesis
United States ProCol Vascular Bioprosthesis is a natural biological graft derived from a bovine mesenteric vein that provides vascular access for end-stage renal disease ("ESRD") hemodialysis patients. It is intended for the creation of a bridge graft for vascular access subsequent to at least one previously failed prosthetic access graft. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-09-11 |
Endospan
Herzlia, Israel Endospan Ltd. is a pioneer in the endovascular repair of Aortic Arch Disease including aneurysms and dissections. Endospan has received CE-Mark to commercialize in Europe the NEXUS™ Stent Graft System, the first endovascular off-the shelf system to treat Aortic Arch Disease which affects a greatly underserved group of patients diagnosed with a dilative lesion in, or near, the aortic arch. While minimally invasive endovascular repair has been the standard of care for Abdominal Aortic Aneurysm (AAA), Aortic Arch Disease patients with aneurysms or dissections have not been as fortunate and have had little choice but to undergo open-chest surgery with its invasiveness and risks, lengthy hospitalization periods, and prolonged recuperation. |
Buy | - |
